Puma Biotechnology Inc (PBYI) — Cash Flow Reinvestment Rate
Puma Biotechnology Inc (PBYI) has a Cash Flow Reinvestment Rate of 1.88x as of December 2025, reinvesting $27.05 Million (capex $36.00K plus investments $-27.01 Million) from operating cash flow of $14.42 Million. See PBYI free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Puma Biotechnology Inc Cash Flow Reinvestment Rate (2019–2025)
Historical reinvestment intensity for Puma Biotechnology Inc across 6 annual periods. For the full cash flow conversion analysis, see Puma Biotechnology Inc cash flow conversion.
Annual Cash Flow Reinvestment Rate for Puma Biotechnology Inc (2019–2025)
Year-by-year capital reinvestment analysis for Puma Biotechnology Inc. See Puma Biotechnology Inc financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.87x | $36.19 Million | $41.80 Million | $71.00K | ▲ +64.4% |
| 2024 | 0.53x | $20.49 Million | $38.92 Million | $56.00K | ▼ -59.9% |
| 2023 | 1.31x | $35.47 Million | $27.01 Million | $12.64 Million | ▲ +149.2% |
| 2021 | 0.53x | $10.88 Million | $20.65 Million | $1.00K | ▼ -99.3% |
| 2020 | 79.37x | $63.49 Million | $800.00K | $20.05 Million | ▲ +30652.5% |
| 2019 | 0.26x | $5.78 Million | $22.38 Million | $306.00K | — |